Drug Delivery Aspects

Drug Delivery Aspects: Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, and scale-up of nano and micro carriers. Various aspects like conversion of micro-nano particles into solid dosage form, large scale industry manufacturing challenges of nanocarriers, regulatory considerations on drug device combinations are featured in this volume. Written by a diverse range of international researchers from industry and academia, the chapters examine specific aspects of characterization and manufacturing for pharmaceutical applications as well as regulatory and policy aspects. The Multifunctional Drug Delivery Systems books provide a platform to discuss opportunities and challenges in development of micro-nanomedicine and other drug delivery systems, review industrial manufacturing challenges, discuss current and future market trends, facilitate the insight sharing within various expertise area, and establish collaborations between academic scientists, industrial and clinical researchers.

This book connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it is a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about the status of drug delivery systems.

• Encompasses engineering aspects of nanocarriers
• Considers preclinical, regulatory and ethical guidelines on drug delivery
• Contains in-depth investigation of specific aspects of drug delivery systems

Pharmaceutical Scientists in academia and industry; pharmacologists; regulatory experts; bioengineers

1. The versatility of hyaluronic acid nanoparticles for drug delivery purposes
   2. Preclinical
   3. NP to oral solid dosage form
   4. Coating in conversion of Nanoemulsions to solid dosage form
   5. Milling techniques-engineering aspect
   6. Role of polymers and excipients in the design and development of amorphous solid dispersions
   7. Biologics: Drug Delivery options and challenges or drug delivery options for biopharmaceuticals
   8. Regulatory Considerations for Drug-Device Combination Products in the EU and the US
   9. Practical Considerations in Active Pharmaceutical Ingredient Design and Development
   10. Sterile processing of pharmaceutical dosage forms: current and future considerations